Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relapsing polychondritis.

Peter D Kent1, Clement J Michet, Harvinder S Luthra

  • 1Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 59905, USA.

Current Opinion in Rheumatology
|December 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of COVID-19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis.

Respirology case reports·2022
Same author

Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.

Mayo Clinic proceedings·2021
Same author

Distinct Single Cell Gene Expression in Peripheral Blood Monocytes Correlates With Tumor Necrosis Factor Inhibitor Treatment Response Groups Defined by Type I Interferon in Rheumatoid Arthritis.

Frontiers in immunology·2020
Same author

Development of biopsy-proven giant cell arteritis in a patient with dermatomyositis on methotrexate: comment on the article by Monti et al.

Clinical and experimental rheumatology·2020
Same author

76-Year-Old Woman With Generalized Weakness.

Mayo Clinic proceedings·2019
Same author

Changes in the Presentation of Incident Gout and the Risk of Subsequent Flares: A Population-based Study over 20 Years.

The Journal of rheumatology·2019
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Relapsing polychondritis is a rare autoimmune disease targeting cartilage, but can affect other organs. This review covers its clinical features, associations, causes, and treatments.

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Background:

  • Relapsing polychondritis (RP) is a rare autoimmune disorder.
  • Characterized by progressive destruction of cartilaginous tissues.
  • Immune-mediated damage can extend to non-cartilaginous tissues, including kidneys and blood vessels.

Purpose of the Study:

  • To summarize key aspects of relapsing polychondritis.
  • Focus on recent advancements in understanding the disease.
  • Provide an overview of clinical manifestations, associations, pathogenesis, and therapeutics.

Main Methods:

  • Literature review of recent studies on relapsing polychondritis.
  • Synthesis of information on clinical presentations and disease associations.
  • Analysis of current understanding of pathogenesis and therapeutic strategies.

Related Experiment Videos

Main Results:

  • Relapsing polychondritis presents with diverse clinical manifestations.
  • The disease can occur primarily or be associated with other conditions.
  • Pathogenesis remains incompletely understood, involving immune system dysregulation.

Conclusions:

  • Relapsing polychondritis is a complex autoimmune condition with potential systemic involvement.
  • Early recognition and comprehensive management are crucial.
  • Ongoing research is vital for improved therapeutic outcomes.